US Stock Market Move | MNSO (MNSO.US) rises over 5%; Q3 revenue up 14.3% year-over-year.
On Tuesday, MNSO (MNSO.US) rose over 5% to $11.89.
On Tuesday, MNSO (MNSO.US) rose over 5% to $11.89. On the news front, on November 17, MNSO Group released its unaudited financial results for the third quarter and first three quarters of 2026.
In the third quarter, MNSO Group achieved revenue of RMB6.625 billion, up 14.3% year-over-year; net profit was RMB291 million, and adjusted net profit was RMB715 million; revenue from its mainland China business grew 29.6% year-over-year. In the first three quarters, the group's revenue was RMB18.124 billion, up 19.3% year-over-year.
In the first three quarters of 2026, sales contribution from the company's proprietary and artist IP products reached a high single-digit percentage, becoming one of the main DRIVE forces behind MNSO's mainland China business growth. In the third quarter, MNSO's mainland China same-store sales achieved high single-digit year-over-year growth, maintaining positive growth for six consecutive quarters.
The warming of both IP products and individual stores jointly supported the performance for the quarter.
Related Articles

YUM CHINA (09987) repurchased 35,600 shares on November 16 for approximately HK$14.1806 million.

GLOBAL BIO-CHEM (00809) intends to sell all equity interests in Changchun Dacheng Bio-Technology through public tender.

NIKE, Inc. Class B (NKE.US) lays out a clear growth path for the next five years: targeting US$5 billion in incremental revenue by fiscal 2031.
YUM CHINA (09987) repurchased 35,600 shares on November 16 for approximately HK$14.1806 million.

GLOBAL BIO-CHEM (00809) intends to sell all equity interests in Changchun Dacheng Bio-Technology through public tender.

NIKE, Inc. Class B (NKE.US) lays out a clear growth path for the next five years: targeting US$5 billion in incremental revenue by fiscal 2031.






